Month: October 2019

Type 1 diabetes has no cure, and although there are several treatment options available, many people find managing the condition challenging. New technology could help reduce that burden. Share on PinterestMany people find managing type 1 diabetes inconvenient, but new research may change this. More than 1 million children and adults in the United States
0 Comments
An employee picks up a Juul Labs device kit for a customer at a store in San Francisco. David Paul Morris | Bloomberg | Getty Images WASHINGTON, D.C. — Leading vaping company Juul won’t likely win regulatory approval to keep its e-cigarettes on the market, former Food and Drug Administration Commissioner David Kessler said in an
0 Comments
It is normal for people to feel sleepy from time to time, particularly after a long day. However, excessive sleepiness can be disruptive and make it difficult for a person to go about their normal daily activities. Some of the more common causes of excessive sleepiness include not sleeping long enough and having poor quality
0 Comments
Calcium channel blockers are a type of medication that people take to increase the flow of blood and oxygen to the heart. Doctors may prescribe a calcium channel blocker to treat high blood pressure or a variety of heart conditions. Calcium channel blockers are common medications that have a low risk of complications. In this
0 Comments
NEW ORLEANS — Asthma patients hospitalized for myocardial infarction (MI) had lower mortality risk than patients without asthma a year after the event, analysis of a nationwide hospital inpatient database indicated. Inpatient mortality was lower in patients with asthma vs controls in the examination of data on approximately 13,000 patients with and without asthma from
0 Comments
Gut bacteria, specifically Prevotella histicola, have anti-inflammatory benefits that could help treat autoimmune disorders such as rheumatoid arthritis, lupus and ankylosing spondylitis. Researchers examined the possibility using mice, and more studies are planned. Mayo Clinic rheumatology chair Eric Matteson, M.D., explains why this is a hot area of research.
0 Comments
Mohanraj Thirumalai, Ph.D., has received a three-year National Institute on Disability, Independent Living and Rehabilitation Research grant to investigate and develop an artificial intelligence-assisted telecoaching solution for people with disabilities and diabetes. Think of the virtual assistant apps, plus the apps that give you recommendations, and then think about how they can work for health
0 Comments
Angiotensin converting enzyme, or “ACE” inhibitors, are a type of medication that doctors prescribe to treat high blood pressure, or “hypertension,” and other cardiovascular conditions. This article outlines the different ACE inhibitors that are available. We also discuss the effectiveness of ACE inhibitors, along with their potential side effects and risks. Share on PinterestA person
0 Comments
New research suggests that a diet high in salt may promote cognitive decline by destabilizing levels of the protein tau. Excessive levels of tau are a hallmark of dementia. Share on PinterestAvoiding excessive salt intake could stave off dementia. Dr. Giuseppe Faraco, an assistant professor of research in neuroscience in the Feil Family Brain and
0 Comments
Chris Ratcliffe | Bloomberg | Getty Images The number of cases of a deadly lung illness linked to vaping appears to be “leveling off or even declining,” a Centers for Disease Control and Prevention official said Friday. “It’s serious and potentially fatal, but it is preventable,” Dr. Anne Schuchat, the CDC’s principal deputy director, told
0 Comments
The Society for Medical Decision Making (SMDM) awarded Regenstrief Institute researcher Stephen Downs, M.D., M.S., with the John M. Eisenberg Award for Practical Application of Medical Decision Making Research. The award recognizes individuals or organizations for sustained leadership in translating medical decision-making research into practice and work to communicate those findings to policymakers and the
0 Comments
NEW ORLEANS – A wearable oscillating vest, designed for treatment of cystic fibrosis, appeared to reduce chronic obstructive pulmonary disease (COPD) exacerbations, according to a retrospective study reported here. After 24 months of wearing the vest, patients achieved a 54.4% reduction in the annualized hospitalization rate for respiratory causes — a reduction in the rate
0 Comments
Everyone has one of those days, now and then, from the minute you wake up, you’re dragging. But for people with postural orthostatic tachycardia syndrome (POTS), those days are the norm. People with POTS may look fine, but they feel terrible, making it hard for other people to understand. POTS impacts your autonomic nervous system,
0 Comments
Inflammatory breast cancer is a rare form of breast cancer. It is often an extremely aggressive cancer that can grow and spread quickly, sometimes within days. According to the National Cancer Institute, inflammatory breast cancer only accounts for 1–5% of all cases of breast cancer that doctors diagnose in the United States. Keep reading to
0 Comments
Having a diagnosis of post-traumatic stress disorder (PTSD) or another stress-related condition may increase the risk of acquiring certain infections, according to a new study. People with a stress-related condition may be predisposed to infections. Despite what some 17th century philosophers taught us, our minds and bodies are not separate entities. In fact, modern scientific
0 Comments
NYU Langone Health and its Perlmutter Cancer Center have launched clinical whole genome DNA methylation profiling for patients with brain tumors. This leading-edge molecular assay utilizes DNA epigenetic signatures and artificial intelligence with machine learning to correctly identify and subtype brain tumors. NYU Langone Health is the first Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory in
0 Comments
Biogen, a multinational biotechnology company, and Eisai, a Japanese pharmaceutical company, are planning to file for Food and Drug Administration (FDA) approval for an Alzheimer’s drug that had mixed results in clinical trials. Can this controversial medication offer fresh hope to millions of people worldwide? A multinational biotech company will push for the regulation of
0 Comments
The U.S. judicial system will ultimately block a court ruling that questioned the constitutionality of Obamacare, Centene CEO Michael Neidorff told CNBC on Thursday. A federal appeals court in New Orleans is expected to soon hand down a decision on the legality of the Affordable Care Act, the landmark health-care law enacted under President Barack
0 Comments
Narcís Pares, a member of the Cognitive Media Technologies research group of the Department of Information and Communication Technologies (DTIC) at UPF, is working on a research line known as “full-body interaction”. At his laboratory, he designs different applications based on such interaction in order to study the mediation of experiences. In these contexts, FUBImethod
0 Comments
NEW ORLEANS — In a subgroup analysis of the ASCENT-COPD trial results, use of the long-acting inhaled muscarinic antagonist (LAMA) aclidinium bromide (Tudorza) was associated with a reduced risk for exacerbations and a similar safety profile in patients with and without a recent history of exacerbations. Original findings from the trial, published last spring, showed
0 Comments